Twist Bioscience Is Maintained at Overweight by Barclays

Twist Bioscience Is Maintained at Overweight by Barclays

Dow JonesJun 29 00:12

Express News | Twist Bioscience : Barclays Raises Target Price to $60 From $45

BreakingsJun 28 19:24

Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $60

Barclays analyst Luke Sergott maintains $Twist Bioscience(TWST.US)$ with a buy rating, and adjusts the target price from $45 to $60.According to TipRanks data, the analyst has a success rate of 40.5%

Futu NewsJun 28 17:31 · Ratings

Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation

Yahoo FinanceJun 14 20:03

Twist Bioscience Is Maintained at Buy by TD Cowen

Twist Bioscience Is Maintained at Buy by TD Cowen

Dow JonesJun 14 00:52

TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $65

TD Cowen analyst Steven Mah maintains Twist Bioscience with a Buy and raises the price target from $55 to $65.

Analyst UpgradesJun 14 00:42